Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
We read with interest an article by Chopra and colleagues1 in a recent issue of JAMA Internal Medicine, and using their study as a starting point, we critically evaluated the activity of our peripherally inserted central catheters (PICC) team. We established our PICC team in January 2013 to address the needs of and care for oncologic patients requiring the availability of reliable long- to medium-term venous access owing to the particular complexity of the chemotherapy regimens, the frequent need for a nutritional or transfusional support, and periodic blood sampling. In June 2013 we launched a learning program for nurses about the management of central venous access. In 2016 the course was opened to physicians and was centered just on the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Guidelines2 and the recently published European Society of Medical Oncology (ESMO) Guidelines.3
Mordenti P, Oleari F, Cavanna L. Peripherally Inserted Central Catheters—Improving Appropriateness With a Dedicated and Rigorous Team. JAMA Intern Med. 2016;176(8):1225. doi:10.1001/jamainternmed.2016.3295